(3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione

C26H21NO2 — CID 2006130

IUPAC(3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione
SMILESCc1ccc(N2C(=O)C[C@@]3(CC4c5ccccc5C3c3ccccc34)C2=O)cc1
InChIInChI=1S/C26H21NO2/c1-16-10-12-17(13-11-16)27-23(28)15-26(25(27)29)14-22-18-6-2-4-8-20(18)24(26)21-9-5-3-7-19(21)22/h2-13,22,24H,14-15H2,1H3/t22?,24?,26-/m1/s1
InChIKeyOESOBPSXIRIDQX-HNHZEOAVSA-N
MW379.46 g/mol
LogP4.93
Rot. Bonds1

About (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione

(3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione (PubChem CID 2006130) has the molecular formula C26H21NO2 and a molecular weight of 379.46 g/mol. Its IUPAC name is (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione.

Molecular Properties

Compound Name(3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione
PubChem CID2006130
Molecular FormulaC26H21NO2
Molecular Weight379.46 g/mol
Exact Mass379.16
IUPAC Name(3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione
SMILESCc1ccc(N2C(=O)C[C@@]3(CC4c5ccccc5C3c3ccccc34)C2=O)cc1
InChIInChI=1S/C26H21NO2/c1-16-10-12-17(13-11-16)27-23(28)15-26(25(27)29)14-22-18-6-2-4-8-20(18)24(26)21-9-5-3-7-19(21)22/h2-13,22,24H,14-15H2,1H3/t22?,24?,26-/m1/s1
InChIKeyOESOBPSXIRIDQX-HNHZEOAVSA-N
XLogP4.93
TPSA37.38 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds1
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500379.46
LogP ≤ 54.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione?
The IUPAC name of (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione (CID 2006130) is (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione.
What is the SMILES notation for (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione?
The canonical SMILES for (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione is Cc1ccc(N2C(=O)C[C@@]3(CC4c5ccccc5C3c3ccccc34)C2=O)cc1.
What is the InChIKey of (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione?
The InChIKey is OESOBPSXIRIDQX-HNHZEOAVSA-N. The full InChI is InChI=1S/C26H21NO2/c1-16-10-12-17(13-11-16)27-23(28)15-26(25(27)29)14-22-18-6-2-4-8-20(18)24(26)21-9-5-3-7-19(21)22/h2-13,22,24H,14-15H2,1H3/t22?,24?,26-/m1/s1.
What are the key properties of (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione?
(3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione has a molecular weight of 379.46 g/mol, XLogP of 4.93, 1 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-1-(4-methylphenyl)spiro[pyrrolidine-3,15'-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaene]-2,5-dione is sourced from PubChem (CID 2006130), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).